Molecular targeting and signal transduction
Collection : Cancer treatment and research . v. 119 Publié par : Kluwer Academic Publishers (Boston) Détails physiques : viii, 331 pages illustrations 24 cm. ISBN :1402078226; 9781402078224; 1402078471 (eBook); 9781402078477 (eBook).| Type de document | Site actuel | Cote | Statut | Date de retour prévue | Code à barres | Réservations |
|---|---|---|---|---|---|---|
| Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616.994 06 KUM (Parcourir l'étagère) | Disponible | 0000000021841 |
Survol La bibliothèque des Sciences Médicales et Pharmaceutiques Étagères Fermer l'étagère
|
|
|
|
|
|
|
||
| 616.994 059 SPI Cancer surgery in the elderly | 616.994 06 BLU VOL.2 Chemosensitivity: | 616.994 06 HAM Genomics in cancer drug discovery and development | 616.994 06 KUM Molecular targeting and signal transduction | 616.994 06 LUS Targeted cancer immune therapy | 616.994 06 OLV The MASCC textbook of cancer supportive care and survivorship | 616.994 061 FOJ The role of microtubules in cell biology, neurobiology, and oncology / |
Brings together up-to-date summaries by leading cancer researchers on the major principles of cancer cell biology: survival, apoptosis, adhesion, and cell cycle deregulation. It is directed at clinicians and scientists working in the areas of experimental and molecular therapeutics, molecular medicine, translational cancer research, and bio-medical sciences in general.
Includes bibliographical references and index.
Biology of the Epidermal Growth Factor Receptor Family -- Integrin Signaling in Cancer -- Regulators of Vascular Endothelial Growth Factor Expression in Cancer -- Integrin-Linked Kinase (ILK) in Combination Molecular Targeting -- p21-Activated Kinase 1: An Emerging Therapeutic Target -- Basis and Importance of Src as a Target in Cancer -- Therapeutic Targeting of the Receptor Tyrosine Kinase Met -- Nuclear Factor -- kB Activation Mediates Cellular Transformation, Proliferation, Invasion, Angiogenesis and Metastasis of Cancer -- The p53 Pathway: Targets for the Development of Novel Cancer Therapeutics -- Runx Protein Signaling in Human Cancers -- Signal Transduction Mediated by Cyclin D1: From Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential -- Signal Transduction Pathways in Bcr-Abl Transformed Cells -- Estrogen Receptors and Anti-Estrogen Therapies -- Targeting Endothelin Axis in Cancer -- km23: A Novel TGFb Signaling Target Altered in Ovarian Cancer.


Il n'y a pas de commentaire pour ce document.